Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice

Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin

P-glycoprotein-deficient mice have proximal tubule dysfunction but are protected against ischemic renal injury

Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE*3Leiden transgenic mice

Amlodipine and atorvastatin in atherosclerosis: A review of the potential of combination therapy